Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings

Shares (Q2 2026)
42,111
Value
$59.0K
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of CHRS by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202642,111$59.0K<0.1%−191,835−82.0%ReducedHolders
Q1 2026233,946$395.4K<0.1%+233,946NewHolders
Q4 20250$00.0%−331,155−100.0%Sold outHolders
Q3 2025331,155$543.1K<0.1%+197,129+147.1%AddedHolders
Q2 2025134,026$98.0K<0.1%+134,026NewHolders
Q4 20240$00.0%−2,857,208−100.0%Sold outHolders
Q3 20242,857,208$2.97M<0.1%+13,760+0.5%AddedHolders
Q2 20242,843,448$4.92M<0.1%+100,821+3.7%AddedHolders
Q1 20242,742,627$6.55M<0.1%+754,730+38.0%AddedHolders
Q4 20231,987,897$6.62M<0.1%−671,820−25.3%ReducedHolders
Q3 20232,659,717$9.95M<0.1%−3,320,003−55.5%ReducedHolders
Q2 20235,979,720$25.5M<0.1%+4,482,817+299.5%AddedHolders
Q1 20231,496,903$10.2M<0.1%+183,560+14.0%AddedHolders
Q4 20221,313,343$10.4M<0.1%+1,123,781+592.8%AddedHolders
Q3 2022189,562$1.82M<0.1%+189,562NewHolders
Q2 20220$00.0%−125,938−100.0%Sold outHolders
Q1 2022125,938$1.63M<0.1%+51,797+69.9%AddedHolders
Q4 202174,141$1.18M<0.1%−116,283−61.1%ReducedHolders
Q3 2021190,424$3.06M<0.1%+174,046+1,062.7%AddedHolders
Q2 202116,378$227.0K<0.1%−407,421−96.1%ReducedHolders
Q1 2021423,799$6.19M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.